Faculty

Current Position

Professor, Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University.

Office

Room 521, Nursing Building

Academic Degrees

AHRQ-Postdoctoral Fellow
   School of Public Health, University of California at Berkeley
   The Nicholas C. Petris Center
   Project: Global ADHD Medication Expenditure Analysis

Ph.D.- Health Policy and Management, Johns Hopkins University
     Dissertation: International Comparison Patients' Willingness to Pay for Cataract Surgery.

 

Specialty

Economic Evaluation, Medical Decision Making, Hospital and Health Care Management

Experience

Associate Professor, Institute of Hospital and Health Care Administration, NYMU, Taiwan.
AHRQ Postdoctoral fellow at School of Public Health, UC Berkeley
Assistant Professor, Institute of Hospital and HealthCare Administration, School of Medicine, National Yang-Ming University, Taiwan

Research Interests

Patient Outcome and quality of Life, Cost of Illness, Cost-Benefit Analysis, Cost-Effectiveness Analysis, Cost-Utility Analysis, Hospital and Health Care Management

 Publication

• Tzeng YH, Yin WH, Lin KC, Wei J, Liou HR, Sung HJ, Lang HC. (2022, Aug). Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel Analysis. Journal of 
  Medical Internet Research, 4(8):e40288. 本人為通訊作者.
• Chiu CM, Chen MS, Lin CS, Lin WY, Lang HC (2022, Apr). Evaluating the comparative efficiency of medical centers in Taiwan: a dynamic data envelopment analysis application. BMC Health Serv Res., 22(1):435. 本人為通 訊作者.
• Chiou LJ, Lang HC (2022, Mar). Potentially preventable hospital readmissions after patients' first stroke in Taiwan. Scientific Reports, 12(1):3743. 本人為通訊 作者.
• Leung JH, Chang CW, Chan AL, Lang HC (2022, Mar). Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan. Future Oncology, 18(7):859-870. 本人為通訊作者.
• Lin CS, Chiu CM, Huang YC, Lang HC, Chen MS (2021, Dec). Evaluating the Operational Efficiency and Quality of Tertiary Hospitals in Taiwan: The Application of the EBITDA Indicator to the DEA Method and TOBIT 
  Regression. Healthcare. 本人為通訊作者.
• Leung JH, Lang HC, Wang SY, Lo HF, Chan AL. (2021, Aug). Costeffectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer. Expert Rev Pharmacoecon Outcomes Res. , doi: 10.1080/14737167.2021.1954506. MOST 
  107-2410-H-010-011.
• Leung WC, Lang HC, Wang SY, Leung H, Chan LF (2021, Jun). Cost utility ‐analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neck. . Expert Review of Pharmacoeconomics & Outcomes Research, 21(3):489-495.. (SCI). MOST 107-2410-H-010-011.
• Yang CP, Li CY, Huang WJ, Yu HL, Yang CC, Lu MC, Lang HC*, Yan YH* (2021, Apr). Short-, mid- and long-term associations between PM2.5 and stroke incidence in Taiwan. Journal of Occupational and Environmental Medicine, doi: 
• 1097/JOM.0000000000002222. . MOST 105-2410-H-010-012-SS2. 本人為 通訊作者.
• Chen TT, Hsueh YS, Chen YH, Lang HC, Fan CM, Wei CJ, Wang TL (2019, May). The validity of acute myocardial infarction process-based measures on public report card: are they varied by patient outcomes at patient- and hospitallevels.. Taiwan J Public Health, 38(3):289-300..
• Yang CP, Cheng HM, LuMC, Lang HC* (2019, May). Association between continuity of care and survival in Taiwanese stroke patients: a 9-year cohort study.. PLos One, 14(5):ee0216495. MOST 105-2410-H-010-012-SS2. 本人為 通訊作者.
• Cheng HM, Chen TC, Chen CH, Lang HC* (2019, Feb). Real-world costeffectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease-A five-year follow-up study.. Health Policy, 123(2):229-234.. MOST 105-2410-H-010-012-SS2. 本人為通訊作者.
• Hsu CS, Lang HC, Huang KY, Chao YC, Chen CL. (2018, Nov). Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan.. Hepatology International, Nov;12(6):531-543. doi: 10.1007/s12072-018-9905-7.
• Chang FM, Wang YP, Lang HC, Tsai CF, Hou MC, Lee FY, Lu CL (2017, Sep). Statins decrease the risk of decompensation in HBV- and HCV-related cirrhosis: a population-based study.. Hepatology, 66(3):896-907.
• Sung SH, Chen TC, Cheng HM, Lee JC, Lang HC, Chen CH (2017, Jan). Comparison of Clinical Outcomes in Patients Undergoing Coronary Intervention with Drug-Eluting Stents or Bare-Metal Stents: A Nationwide Population Study.. Acta Cardiol Sin., 33(1):10-19.
• 蔣靜怡,郎慧珠（2017年12月）。台灣診所之歇業與存活研究及其相關因素 探討─以2000年至2010年新設西醫診所研究為例。台灣衛誌，2017；36(6)：626-639.。本人為通訊作